Amgen deal for Onyx possible within week: sources

NEW YORK (Reuters) – Onyx Pharmaceuticals Inc is close to selling itself to larger rival Amgen Inc as the cancer drugmaker’s high stock price has discouraged other companies from making a counteroffer so far, according to three people familiar with the matter.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.